Selected research
Industry Growth & Trends
Global Rilpivirine Industry Growth and Trends Forecast to 2032
Market perspective
The global Rilpivirine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Rilpivirine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Rilpivirine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Rilpivirine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Rilpivirine include Aspen, Gilead Sciences, Janssen Cilag International, Pharmacare Limited, Strides Pharma Science Limited and ViiV Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Rilpivirine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Rilpivirine market size, estimates, and forecasts are presented in terms of sales volume (k pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Rilpivirine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Rilpivirine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Rilpivirine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Rilpivirine Market by Company
Aspen
Gilead Sciences
Janssen Cilag International
Pharmacare Limited
Strides Pharma Science Limited
ViiV Healthcare
Rilpivirine Segment by Type
Self-production API
Outsourcing of API
Rilpivirine Segment by Application
Clinic
Hospital
Drug Center
Others
Rilpivirine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rilpivirine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rilpivirine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rilpivirine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rilpivirine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Rilpivirine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Self-production API
- Outsourcing of API
Applications
- Clinic
- Hospital
- Drug Center
- Others
Companies covered
- Aspen
- Gilead Sciences
- Janssen Cilag International
- Pharmacare Limited
- Strides Pharma Science Limited
- ViiV Healthcare
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Rilpivirine Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Rilpivirine Sales Estimates and Forecasts (2021-2032)
- 1.3 Rilpivirine Market by Type
- 1.3.1 Self-production API
- 1.3.2 Outsourcing of API
- 1.4 Global Rilpivirine Market Size by Type
- 1.4.1 Global Rilpivirine Market Size Overview by Type (2021-2032)
- 1.4.2 Global Rilpivirine Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Rilpivirine Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Rilpivirine Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Rilpivirine Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Rilpivirine Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Rilpivirine Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Rilpivirine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Rilpivirine Industry Trends
- 2.2 Rilpivirine Industry Drivers
- 2.3 Rilpivirine Industry Opportunities and Challenges
- 2.4 Rilpivirine Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Rilpivirine Revenue (2021-2026)
- 3.2 Global Top Players by Rilpivirine Sales (2021-2026)
- 3.3 Global Top Players by Rilpivirine Price (2021-2026)
- 3.4 Global Rilpivirine Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Rilpivirine Major Company Production Sites & Headquarters
- 3.6 Global Rilpivirine Company, Product Type & Application
- 3.7 Global Rilpivirine Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Rilpivirine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Rilpivirine Players Market Share by Revenue in 2025
- 3.8.3 2025 Rilpivirine Tier 1, Tier 2, and Tier 3
4 Rilpivirine Regional Status and Outlook
- 4.1 Global Rilpivirine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Rilpivirine Historic Market Size by Region
- 4.2.1 Global Rilpivirine Sales in Volume by Region (2021-2026)
- 4.2.2 Global Rilpivirine Sales in Value by Region (2021-2026)
- 4.2.3 Global Rilpivirine Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Rilpivirine Forecasted Market Size by Region
- 4.3.1 Global Rilpivirine Sales in Volume by Region (2027-2032)
- 4.3.2 Global Rilpivirine Sales in Value by Region (2027-2032)
- 4.3.3 Global Rilpivirine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Rilpivirine by Application
- 5.1 Rilpivirine Market by Application
- 5.1.1 Clinic
- 5.1.2 Hospital
- 5.1.3 Drug Center
- 5.1.4 Others
- 5.2 Global Rilpivirine Market Size by Application
- 5.2.1 Global Rilpivirine Market Size Overview by Application (2021-2032)
- 5.2.2 Global Rilpivirine Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Rilpivirine Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Rilpivirine Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Rilpivirine Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Rilpivirine Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Rilpivirine Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Rilpivirine Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Aspen
- 6.1.1 Aspen Company Information
- 6.1.2 Aspen Business Overview
- 6.1.3 Aspen Rilpivirine Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Aspen Rilpivirine Product Portfolio
- 6.1.5 Aspen Recent Developments
- 6.2 Gilead Sciences
- 6.2.1 Gilead Sciences Company Information
- 6.2.2 Gilead Sciences Business Overview
- 6.2.3 Gilead Sciences Rilpivirine Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Gilead Sciences Rilpivirine Product Portfolio
- 6.2.5 Gilead Sciences Recent Developments
- 6.3 Janssen Cilag International
- 6.3.1 Janssen Cilag International Company Information
- 6.3.2 Janssen Cilag International Business Overview
- 6.3.3 Janssen Cilag International Rilpivirine Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Janssen Cilag International Rilpivirine Product Portfolio
- 6.3.5 Janssen Cilag International Recent Developments
- 6.4 Pharmacare Limited
- 6.4.1 Pharmacare Limited Company Information
- 6.4.2 Pharmacare Limited Business Overview
- 6.4.3 Pharmacare Limited Rilpivirine Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Pharmacare Limited Rilpivirine Product Portfolio
- 6.4.5 Pharmacare Limited Recent Developments
- 6.5 Strides Pharma Science Limited
- 6.5.1 Strides Pharma Science Limited Company Information
- 6.5.2 Strides Pharma Science Limited Business Overview
- 6.5.3 Strides Pharma Science Limited Rilpivirine Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Strides Pharma Science Limited Rilpivirine Product Portfolio
- 6.5.5 Strides Pharma Science Limited Recent Developments
- 6.6 ViiV Healthcare
- 6.6.1 ViiV Healthcare Company Information
- 6.6.2 ViiV Healthcare Business Overview
- 6.6.3 ViiV Healthcare Rilpivirine Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 ViiV Healthcare Rilpivirine Product Portfolio
- 6.6.5 ViiV Healthcare Recent Developments
7 North America by Country
- 7.1 North America Rilpivirine Sales by Country
- 7.1.1 North America Rilpivirine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Rilpivirine Sales by Country (2021-2026)
- 7.1.3 North America Rilpivirine Sales Forecast by Country (2027-2032)
- 7.2 North America Rilpivirine Market Size by Country
- 7.2.1 North America Rilpivirine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Rilpivirine Market Size by Country (2021-2026)
- 7.2.3 North America Rilpivirine Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Rilpivirine Sales by Country
- 8.1.1 Europe Rilpivirine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Rilpivirine Sales by Country (2021-2026)
- 8.1.3 Europe Rilpivirine Sales Forecast by Country (2027-2032)
- 8.2 Europe Rilpivirine Market Size by Country
- 8.2.1 Europe Rilpivirine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Rilpivirine Market Size by Country (2021-2026)
- 8.2.3 Europe Rilpivirine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Rilpivirine Sales by Country
- 9.1.1 Asia-Pacific Rilpivirine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Rilpivirine Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Rilpivirine Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Rilpivirine Market Size by Country
- 9.2.1 Asia-Pacific Rilpivirine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Rilpivirine Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Rilpivirine Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Rilpivirine Sales by Country
- 10.1.1 South America Rilpivirine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Rilpivirine Sales by Country (2021-2026)
- 10.1.3 South America Rilpivirine Sales Forecast by Country (2027-2032)
- 10.2 South America Rilpivirine Market Size by Country
- 10.2.1 South America Rilpivirine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Rilpivirine Market Size by Country (2021-2026)
- 10.2.3 South America Rilpivirine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Rilpivirine Sales by Country
- 11.1.1 Middle East and Africa Rilpivirine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Rilpivirine Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Rilpivirine Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Rilpivirine Market Size by Country
- 11.2.1 Middle East and Africa Rilpivirine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Rilpivirine Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Rilpivirine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Rilpivirine Value Chain Analysis
- 12.1.1 Rilpivirine Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Rilpivirine Production Mode & Process
- 12.2 Rilpivirine Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Rilpivirine Distributors
- 12.2.3 Rilpivirine Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst